JLL Extends Patheon Offer
May 11, 2009- Share:
JLL Partners announced that it has acquired 35% of Patheon's restricted voting stock through its $2 per share offer and is extending the offer deadline until May 19. If JLL converted its preferred shares from a $150 million investment in the company it would hold 55% of the company's restricted voting shares. Patheon provides contract dosage form development and manufacturing services to the pharmaceutical and biotechnology industries.
- Share:
-
-
-
-